ProBioGen's Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production
BERLIN, Germany, January 18, 2023 / B3C newswire / -- ProBioGen is announcing another important clinical milestone for its proprietary viral vector and vaccine production cell line AGE1.CRpIX®. Our valued customer Nouscom recently proclaimed that their sub-licensee, has initiated phase 1 clinical trials for VAC85135...